...
首页> 外文期刊>Surgical Endoscopy >Robotic surgery trends in general surgical oncology from the National Inpatient Sample
【24h】

Robotic surgery trends in general surgical oncology from the National Inpatient Sample

机译:来自国家住院样本的一般手术肿瘤的机器人手术趋势

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundRobotic surgery is offered at most major medical institutions. The extent of its use within general surgical oncology, however, is poorly understood. We hypothesized that robotic surgery adoption in surgical oncology is increasing annually, that is occurring in all surgical sites, and all regions of the US.Study designWe identified patients with site-specific malignancies treated with surgical resection from the National Inpatient Sample 2010-2014 databases. Operations were considered robotic if any ICD-9-CM robotic procedure code was used.ResultsWe identified 147,259 patients representing the following sites: esophageal (3%), stomach (5%), small bowel (5%), pancreas (7%), liver (5%), and colorectal (75%). Most operations were open (71%), followed by laparoscopic (26%), and robotic (3%). In 2010, only 1.1% of operations were robotic; over the 5-year study period, there was a 5.0-fold increase in robotic surgery, compared to 1.1-fold increase in laparoscopy and 1.2-fold decrease in open surgery (<0.001). These trends were observed for all surgical sites and in all regions of the US, they were strongest for esophageal and colorectal operations, and in the Northeast. Adjusting for age and comorbidities, odds of having a robotic operation increased annually (5.6 times more likely by 2014), with similar length of stay (6.96.5 vs 7.0 +/- 6.5, p=0.52) and rate of complications (OR 0.91, 95% CI 0.83-1.01, p=0.08) compared to laparoscopy.Conclusions Robotic surgery as a platform for minimally invasive surgery is increasing over time for oncologic operations. The growing use of robotic surgery will affect surgical oncology practice in the future, warranting further study of its impact on cost, outcomes, and surgical training.
机译:Backgroundrobotic手术是在大多数主要医疗机构提供的。然而,其在一般外科肿瘤内使用的程度都很明显。我们假设手术肿瘤学中的机器人手术通过每年增加,即在所有手术部位以及US.Study Designwe的所有区域都发现了用来自国家住院病样品2010-2010数据库的手术切除治疗的特异性特异性恶性肿瘤的患者。如果使用任何ICD-9-CM机器人程序代码,则被认为是机器人。鉴定了147,259名代表下列地点的患者:食道(3%),胃(5%),小肠(5%),胰腺(7%) ,肝脏(5%)和结直肠(75%)。大多数业务开放(71%),其次是腹腔镜(26%)和机器人(3%)。 2010年,只有1.1%的业务是机器人;在5年的研究期间,机器人手术增加了5.0倍,而腹腔镜检查的增加1.1倍,开放手术的减少1.2倍(<0.001)。所有手术部位和美国的所有地区都观察到这些趋势,它们对食管和结肠直肠作业最强,并在东北部位。调整年龄和合并症,机器人操作的几率每年增加(到2014年的可能性5.6倍),具有相似的逗留时间(6.96.5 Vs 7.0 +/- 6.5,p = 0.52)和并发症率(或0.91与腹腔镜检查相比,95%CI 0.83-1.01,P = 0.08)。结论机器人手术作为微创手术的平台,随着时间的推移,肿瘤作用随着时间的推移而增加。越来越多的机器人手术将在未来影响外科肿瘤学实践,需要进一步研究其对成本,结果和外科手术的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号